Company: HCTI
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026218
Chunk: 334

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 334
---
 remeasured at $625,
resulting in a gain of $1,602, which was recognized as “Gain on revaluation” in the consolidated income statement. The gain
on revaluation was $0 in the financial year 2023.

The Company has a payout of $625 for financial
year 2022 and $0 for financial year 2023 arising from the Devcool Inc, acquisition. During the year ended December 31, 2023, the company
issued 31,250 common stocks valued at $125 towards settlement of the contingent consideration and the balance $500 is outstanding as of
December 31, 2024.

On February 24, 2025, the Company executed a settlement
agreement and issued 594,130 common stocks at 10-day VWAP of $0.6733 amounting to $400 and the balance $100 to be settled by cash on March
31, 2025.

F-19

8) Equity Transactions

The Company issued 50,000 common stocks amounting
to $22 and 30,000 common stocks amounting to $108 as Consulting fees for services for the year ended December 31, 2024, and December 31,
2023, respectively. The fair value of the shares issued for services was calculated using the closing share price on date of grant.

The Company issued 558,958 shares of common stock
at a price of $1.71 per share and 76,923 shares of common stock at a price of $6.50 per share for total cash proceeds of approximately
$956 and $500 for the year ended December 31, 2024, and December 31, 2023, respectively.

The Company issued nil and 31,250 common stocks
at a price of $4 amounting $125 towards the equity earnout for the year ended December 31, 2024, and December 31, 2023, respectively.

On May 26, 2023, the Company effected a one-for-ten (1:10) reverse stock split of its outstanding common stock to be in compliance with
the $1.00 minimum bid price requirement for continued listing. As a result of the reverse stock split, all previous and forward-looking
shares have been adjusted to the split. The Company’s issued and outstanding common stock were combined into one new share of common
stock resulting in a reduction of 304 rounding shares.

Preferred Stock

The Company